Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?
作者信息
Dimitriu-Leen Aukelien C, Scholte Arthur J H A
机构信息
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Postal zone 2300 RC, 2333 ZA, Leiden, The Netherlands.
出版信息
J Nucl Cardiol. 2017 Jun;24(3):900-902. doi: 10.1007/s12350-015-0380-4. Epub 2016 Jan 4.
Abstract
摘要
相似文献
1
Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?非酒精性脂肪性肝病患者肝脏的氟代脱氧葡萄糖摄取：心脑血管事件的一个重要预后因素？
J Nucl Cardiol. 2017 Jun;24(3):900-902. doi: 10.1007/s12350-015-0380-4. Epub 2016 Jan 4.
2
Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.在非酒精性脂肪性肝病的无症状个体中，肝脏对氟代脱氧葡萄糖（FDG）的摄取与未来心血管事件相关。
J Nucl Cardiol. 2017 Jun;24(3):892-899. doi: 10.1007/s12350-015-0297-y. Epub 2015 Oct 28.
3
Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.心肌FDG摄取减少的非酒精性脂肪性肝病与冠状动脉粥样硬化有关。
J Nucl Cardiol. 2021 Apr;28(2):610-620. doi: 10.1007/s12350-019-01736-6. Epub 2019 May 10.
4
Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by F-fluorodeoxyglucose positron emission tomography.非酒精性脂肪性肝病与 F-氟代脱氧葡萄糖正电子发射断层扫描测量的心肌葡萄糖摄取之间的关系。
J Nucl Cardiol. 2020 Oct;27(5):1679-1688. doi: 10.1007/s12350-018-1446-x. Epub 2018 Sep 20.
5
Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.肝葡萄糖摄取增加与血清γ-谷氨酰转肽酶和甘油三酯升高有关。
Dig Dis Sci. 2014 Mar;59(3):607-13. doi: 10.1007/s10620-013-2957-6. Epub 2013 Dec 11.
6
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.非酒精性脂肪性肝炎与非肝硬化患者亚临床心肌功能障碍的相关性。
J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24.
7
FDG PET/CT of the non-malignant liver in an increasingly obese world population.日益肥胖的世界人口中的非恶性肝脏的 FDG PET/CT。
Clin Physiol Funct Imaging. 2020 Sep;40(5):304-319. doi: 10.1111/cpf.12651. Epub 2020 Jul 15.
8
Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.通过18F-氟脱氧葡萄糖正电子发射断层扫描评估非酒精性脂肪性肝病与颈动脉炎症之间的关联。
Angiology. 2015 May;66(5):472-80. doi: 10.1177/0003319714537872. Epub 2014 Jun 5.
9
Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.18F-FDG PET/CT对非酒精性脂肪肝肝脏代谢活性的评估
Rev Esp Med Nucl Imagen Mol. 2013 May-Jun;32(3):156-61. doi: 10.1016/j.remn.2012.04.006. Epub 2012 May 31.
10
Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by F-fluorodeoxyglucose positron emission tomography.血管炎症与非酒精性脂肪性肝病之间的关联：通过F-氟脱氧葡萄糖正电子发射断层扫描进行分析
Metabolism. 2017 Feb;67:72-79. doi: 10.1016/j.metabol.2016.11.004. Epub 2016 Nov 6.
引用本文的文献
1
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.数字肝脏活检：用于转化研究和临床研究的脂肪肝生物成像
World J Hepatol. 2018 Feb 27;10(2):231-245. doi: 10.4254/wjh.v10.i2.231.
本文引用的文献
1
Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.在非酒精性脂肪性肝病的无症状个体中，肝脏对氟代脱氧葡萄糖（FDG）的摄取与未来心血管事件相关。
J Nucl Cardiol. 2017 Jun;24(3):892-899. doi: 10.1007/s12350-015-0297-y. Epub 2015 Oct 28.
2
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描：欧洲核医学与分子影像学会肿瘤显像程序指南：第2.0版。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
3
Accumulation of (18)F-FDG in the liver in hepatic steatosis.在肝脂肪变性中，(18)F-FDG 在肝脏中的积累。
AJR Am J Roentgenol. 2014 Sep;203(3):643-8. doi: 10.2214/AJR.13.12147.
4
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.肝活检及非侵入性诊断测试在非酒精性脂肪性肝病/非酒精性脂肪性肝炎诊断中的局限性
World J Gastroenterol. 2014 Jan 14;20(2):475-85. doi: 10.3748/wjg.v20.i2.475.
5
Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.肝葡萄糖摄取增加与血清γ-谷氨酰转肽酶和甘油三酯升高有关。
Dig Dis Sci. 2014 Mar;59(3):607-13. doi: 10.1007/s10620-013-2957-6. Epub 2013 Dec 11.
6
Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.肝移植治疗非酒精性脂肪性肝炎：新的流行疾病。
Ann Surg. 2012 Oct;256(4):624-33. doi: 10.1097/SLA.0b013e31826b4b7e.
7
The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET.脂肪肝对 FDG PET 肝脏最大标准摄取值的负面影响。
Clin Imaging. 2011 Nov-Dec;35(6):437-41. doi: 10.1016/j.clinimag.2011.02.005.
8
Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.肝脂肪变性患者 FDG PET/CT 检查的肝脏代谢活性改变。
AJR Am J Roentgenol. 2011 Jan;196(1):176-80. doi: 10.2214/AJR.10.4679.
9
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept.应用 FDG-PET 和 MRI 对弥漫性脂肪肝患者和正常对照者进行肝脏代谢容积产物的定量评估：一种新的概念。
Mol Imaging Biol. 2010 Jun;12(3):233-9. doi: 10.1007/s11307-009-0258-4. Epub 2009 Oct 6.
10
Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.放射性药物对患者的辐射剂量。国际放射防护委员会第53号出版物补编3。国际放射防护委员会第106号出版物。2007年10月获委员会批准。
Ann ICRP. 2008;38(1-2):1-197. doi: 10.1016/j.icrp.2008.08.003.
Zotero 插件